Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 15 2023 - 12:49PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the
month of May 2023
Commission File
Number 001-15170
GSK
plc
(Translation of
registrant's name into English)
980
Great West Road, Brentford, Middlesex, TW8 9GS
(Address of
principal executive office)
Indicate by check
mark whether the registrant files or will file annual reports under
cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
BLOCK LISTING SIX MONTHLY RETURN
Date: 15
May 2023
|
Name of applicant:
|
GSK
plc
|
|
Name
of scheme:
|
GlaxoSmithKline
plc 2017 Deferred Annual Bonus Plan
|
|
Period
of return:
|
From:
|
1
November 2022
|
To:
|
30
April 2023
|
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
44,219
|
|
Plus: The
amount by which the block scheme(s) has been increased since the
date of the last return (if any increase has been applied
for):
|
400,000
|
|
Less: Number
of securities issued/allotted under scheme(s) during
period (see LR3.5.7G):
|
172,912
|
|
Equals: Balance
under scheme(s) not yet issued/allotted at end of
period:
|
271,307
|
|
Name of applicant:
|
GSK
plc
|
|
Name
of scheme:
|
GlaxoSmithKline
plc Share Save Plan 2012
|
|
Period
of return:
|
From:
|
1
November 2022
|
To:
|
30
April 2023
|
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
1,121,875
|
|
Plus: The
amount by which the block scheme(s) has been increased since the
date of the last return (if any increase has been applied
for):
|
0
|
|
Less: Number
of securities issued/allotted under scheme(s) during
period (see LR3.5.7G):
|
563,046
|
|
Equals: Balance
under scheme(s) not yet issued/allotted at end of
period:
|
558,829
|
|
Name of applicant:
|
GSK
plc
|
|
Name
of scheme:
|
GlaxoSmithKline
plc Share Save Plan 2022
|
|
Period
of return:
|
From:
|
1
November 2022
|
To:
|
30
April 2023
|
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
0
|
|
Plus: The
amount by which the block scheme(s) has been increased since the
date of the last return (if any increase has been applied
for):
|
1,000,000
|
|
Less: Number
of securities issued/allotted under scheme(s) during
period (see LR3.5.7G):
|
46
|
|
Equals: Balance
under scheme(s) not yet issued/allotted at end of
period:
|
999,954
|
|
Name
of contact:
|
Victoria
Whyte
|
|
Telephone
number of contact:
|
020
8047 5000
|
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorised.
|
|
GSK
plc
|
|
|
(Registrant)
|
|
|
|
|
Date: May 15,
2023
|
|
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
|
|
Victoria Whyte
|
|
|
Authorised
Signatory for and on
|
|
|
behalf
of GSK plc
|
GSK (NYSE:GSK)
Historical Stock Chart
From Sep 2023 to Oct 2023
GSK (NYSE:GSK)
Historical Stock Chart
From Oct 2022 to Oct 2023
